Business Wire

Citco’s Full-Service Solution Supports Leading Private Equity Firm in Time of Rapid Fund Growth and Strategy Diversification

Share

The Citco Group of Companies (“Citco”), a leading provider of asset servicing solutions to the global alternative investment industry, today confirmed its on-boarding of additional commitments from longstanding client EQT, a leading global investment firm with more than €50 billion in raised capital across 28 funds. The additional commitments were driven by an increase in fund size, significant co-investment activity and broadening of strategies. To enable this expansion, amongst other things, Citco launched its center of excellence for Private Equity investor services and created a dedicated team to manage integrations and support strategic changes by clients through process enhancement initiatives and implementation of customized technology solutions.

Citco provides a full suite of asset servicing and related solutions to EQT’s portfolio of funds and special purpose vehicles, including administration of around €15 billion in new capital commitments across 3 new funds closed during 2018.

The Citco full-service solution provided to EQT since 2014 covers asset servicing, fund administration, fund accounting, corporate secretarial, fund performance reporting, treasury and related needs across its private equity, infrastructure, real estate, private credit, ventures and recently-launched mid-cap public equity funds.

EQT is also an early adopter of Citco’s recently launched Æxeo Treasury, a software-as-a-service offering, to simplify the firm’s day-to-day banking operations and relationships. Citco’s first ‘born-in- the-cloud’ solution, Æxeo Treasury is a stand-alone tool that enables alternative fund managers to improve operational efficiencies by centralizing their treasury functions - including funding investments, settling OTC trades and margin, making transfers between accounts or paying invoices – on a secure state-of-the-art module running on Amazon Web Services.

Patrik Burnäs, Group Head of Fund Operations at EQT, said: “Citco’s experienced staff and technology-based solutions are a seamless extension of our own capabilities, helping EQT to deliver the operational efficiency required to invest across asset classes and geographies. Citco’s deep industry expertise, investments in well working digital solutions and global reach make it an ideal partner to support EQT’s growth and development ambitions.”

Nikolaos Perros, Head of Private Equity fund services at Citco, said: “We are proud of our long-term relationship with EQT, which is well-established as one of the world’s leading private equity firms. EQT’s remarkable growth in recent years reflects a wider trend in the industry in which the most successful players are deploying larger funds across a broader canvas of investment opportunities globally. We at Citco have developed the service capabilities – including people, processes and technologies – to support the administration needs of these mega-funds, with speed, efficiency and at scale.”

Citco will launch a white paper in Q1 2019 highlighting the growth of global ‘mega funds’ in the alternative asset management sector, addressing specifically the challenges of size, scale and complexity faced by industry-leading firms as well as the potential rewards of working with the right partner in solving those challenges. The paper will draw on the insights and experiences of leading practitioners from across the sector, supported by industry data and analytics. To register your interest in receiving news about the publication, please email privateequity@citco.com.

About Citco

The Citco Group of Companies (Citco) is a leading provider of asset servicing solutions to the global alternative investment industry. With over $1 Trillion in assets under administration and 6,500 staff deployed across 40 countries, Citco’s unique culture of innovation and client driven solutions has provided Citco’s clients with a trusted partner for more than four decades. Having grown organically into one of the largest asset servicers in the industry, Citco’s Fund Services division offers a full suite of Middle Office and Back Office services including, treasury and loan handling, daily NAV calculations and investor services, corporate and legal services, regulatory and risk reporting as well as tax and financial reporting services. Investing heavily in innovation and technology whilst further developing its current suite of client friendly solutions, Citco will continue into the future as a flagbearer for the asset servicing industry.

ENDS

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Aryna Kastavetskaya
Aryna.Kastavetskaya@PeregrineCommunications.com
+44 20 3040 0871

Rob Enright
Rob.Enright@PeregrineCommunications.com
+44 20 3040 0874

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Corona Global Named Most Valuable Beer Brand in Kantar BrandZ Rankings for Second Consecutive Year15.5.2025 07:01:00 EEST | Press release

Corona has been recognized as the most valuable beer brand in the world for the second consecutive year in Kantar's BrandZ 2025 Most Valuable Global Brands report, released today. Eight out of the 10 most valuable global beer brands belong to AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD), according to the report ranking the top brands in the world. In 2024 AB InBev produced all-time high revenue and 15% Underlying EPS growth. The year marked double-digit growth for Corona outside of its home market of Mexico and triple-digit growth of its no-alcohol brand Corona Cero. Corona Cero is the first beer brand to sponsor the Olympic Games making its debut in Paris 2024. In 2025, Corona is celebrating its 100-year anniversary with events all over the world through its “Corona 100” platform. Corona is followed by Budweiser, the second most valuable beer brand in the world. Michelob ULTRA moved up one spot to #5 amongst beer brands globally. Michelob ULTRA has also been named the winner

Forrester Opens Nominations For Its 2025 B2B Awards In EMEA And APAC15.5.2025 07:00:00 EEST | Press release

Forrester (Nasdaq: FORR) today opened calls for nominations for its 2025 B2B Return On Integration Honors and B2B Programs Of The Year Awards in Asia Pacific (APAC) and Europe, Middle East, and Africa (EMEA). These awards will recognize B2B organizations based in both regions for achieving functional excellence and outstanding alignment across marketing, sales, and product — the B2B revenue engine — to improve customer experience and drive growth. Nominations for both award categories are open to organizations of all sizes in each region. B2B leaders across APAC and EMEA — including chief marketing officers, chief sales officers, chief product officers, and other marketing, sales, and product leaders — are invited and encouraged to apply. To be eligible, programs need to be developed by leaders and teams based in the APAC or EMEA regions. The nomination criteria for the two awards are as follows: B2B Return On Integration (ROI) Honors. These awards showcase organizations that have achi

Microba Announces Landmark GI Study Results From Over 4,600 Patients15.5.2025 05:12:00 EEST | Press release

Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”), a precision microbiome company, today announces preliminary results from the analysis of over 4,600 MetaXplore™ GI Plus test results, a comprehensive test for the assessment and management of lower gastrointestinal disorders, spanning symptoms including chronic pain, bloating, constipation, or diarrhea. This study demonstrates that MetaXplore can support clinicians to identify and address underlying gut issues that often go undetected by conventional testing. In over 70% of cases, the test revealed findings, such as abnormalities in gut bacteria, signs of infection, markers of inflammation or insufficiency that could inform targeted treatment strategies. Further, two-thirds of MetaXplore patients in a separate study of follow up survey results reported improvement of symptoms after their care was guided by the test results. This press release features multimedia. View the full release here: https://www.businesswire.

Bloomstreet Enters into Strategic Partnership Agreement with Google Israel for Market Expansion in Japan15.5.2025 05:00:00 EEST | Press release

Bloomstreet Inc. (Headquarters: Chuo-ku, Tokyo; President & CEO: Junichi Takayama; hereinafter “Bloomstreet”), a company that supports overseas enterprises entering the Japanese market, is pleased to announce a strategic partnership agreement with Google Israel Ltd. (Headquarters: Tel Aviv District; Country Manager: Barak Regev; hereinafter “Google Israel”). This partnership aims to support Israeli companies that operate globally with Google Ads and are seeking to expand into the Japanese market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250514387485/en/ How do Bloomstreet and Google Israel collaborate? The partnership between Bloomstreet and Google Israel is designed to support Israeli companies seeking to expand into the Japanese market by optimizing their website UI/UX, thereby enhancing the effectiveness of their Google Ads campaigns. Background of the Partnership Known as a "Start-up Nation," Israel is home to many

Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience15.5.2025 04:11:00 EEST | Press release

Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that using open source codes integrated in the company’s broader propriety drug discovery platform, ALEMBIC™, helped to identify senescent neurons in a new study that found senescent neurons drive chronic pain with injury and age.1 Senescent cells, often called “zombie” cells, arise as the results of cellular stress and damage. These senescent cells do not die but undergo cellular changes, including secreting pro-inflammatory factors, thereby potentially contributing to inflammatory responses within the body.1 The study, led by Stanford University scientists, Vivianne Tawfik, MD, PhD, and Lauren Donovan, PhD, and co-authored by Rubedo team members, including Chief Scientific Officer Marco Quarta, PhD, and Chief Technology Officer Alex Laslavic, was published in the May 14th edition of Nat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye